The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.
title = "Antibodies specifically directed to a soluble form of CTLA-4",
abstract = "The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.",
author = "Ward, {Frank James} and Barker, {Robert Norman} and Dahal, {Lekh Nath}",
year = "2010",
month = "9",
day = "2",
language = "English",
type = "Patent",
note = "US8697845 B2",
}
TY - PAT
T1 - Antibodies specifically directed to a soluble form of CTLA-4
AU - Ward, Frank James
AU - Barker, Robert Norman
AU - Dahal, Lekh Nath
PY - 2010/9/2
Y1 - 2010/9/2
N2 - The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.
AB - The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.
UR - https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140415&DB=EPODOC&locale=en_EP&CC=US&NR=8697845B2&KC=B2&ND=5
M3 - Patent
M1 - US8697845 B2
ER -
Access to Document
US8697845B2Final published version, 1.39 MBLicence: Unspecified